Literature DB >> 18636260

Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.

Junichi Sugita1, Junji Tanaka, Aya Hashimoto, Souichi Shiratori, Atsushi Yasumoto, Kentaro Wakasa, Misato Kikuchi, Akio Shigematsu, Yoko Miura, Yutaka Tsutsumi, Takeshi Kondo, Masahiro Asaka, Masahiro Imamura.   

Abstract

We retrospectively analyzed very early chimerism before and ongoing neutrophil engraftment (days 7, 14, 21, 28) and investigated the influence of conditioning regimens and stem cell sources on donor-type chimerism in 59 Japanese patients who had received allogeneic hematopoietic stem cell transplantation. The percentage of donor-type chimerism increased before engraftment in all patients who achieved engraftment. The average percentage of donor-type chimerism in patients who had received reduced-intensity stem cell transplantation (RIST) with total body irradiation (TBI) was significantly higher than that in patients who had received RIST without TBI (98.8% vs 87.5% on day 21, P<0.01; 99.3% vs 84.3% on day 28, P<0.01). The average percentage of donor-type chimerism after peripheral blood stem cell transplantation was significantly higher than that after bone marrow transplantation on day 7 (81.5% vs 43.1%, P<0.01), and the average percentage of donor-type chimerism after cord blood transplantation was significantly lower on day 14 (55.8% vs 84.8%, P<0.05). Compared with the average percentage of donor-type chimerism in patients who achieved engraftment with each stem cell source, a notable decrease in donor-type chimerism was observed in patients who failed to achieve engraftment. This study suggests that differences in conditioning regimens and stem cell sources should be taken into account when considering donor-type chimerism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636260     DOI: 10.1007/s00277-008-0542-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

1.  Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation.

Authors:  Takeshi Kondo; Atsushi Yasumoto; Kotaro Arita; Jun-Ichi Sugita; Akio Shigematsu; Kohei Okada; Mutsumi Takahata; Masahiro Onozawa; Kaoru Kahata; Yukari Takeda; Masato Obara; Satoshi Yamamoto; Tomoyuki Endo; Mitsufumi Nishio; Norihiro Sato; Junji Tanaka; Satoshi Hashino; Takao Koike; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2010-01-20       Impact factor: 2.490

2.  Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.

Authors:  Meerim Park; Kyung Nam Koh; Jong Jin Seo; Ho Joon Im
Journal:  Korean J Hematol       Date:  2011-12-27

3.  Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats.

Authors:  Qingzhen Gao; Xiaoping Wang; Ruibin Zhang; Pu Wang; Yongsheng Jing; Wanjun Ren; Bin Zhu
Journal:  J Diabetes Investig       Date:  2016-01-23       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.